RWD C100 Cell Counter Turnkey System Accurate Fluorescence Analysis
RWD Life Science
Details
-
CategoryCell Counting / Sorting
-
Dimension8.0in x 10.0in x 7.0in
-
SerialN/A
-
Shipping TypeFedEx Ground
-
ManufacturingDoes Not Apply
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The RWD C100 Automated Cell Counter is a high-performing device renowned for its rapid cell counting and analysis. Designed by RWD Life Science in the USA, this turnkey system provides reliable cell counting with intelligent analysis software and superior microscopy optics. Experience precise analysis of stem cells, primary cells, and cell lines in just 15 seconds, or even quicker using the 3-second fast counting mode. User-defined settings allow for customization to reduce errors, ensuring high accuracy with a standard deviation of less than 5%. With a 7-inch high-definition touch screen, ergonomic design, and disposable counting slides, it reduces operator strain and risk of biological hazards. Ideal for labs aiming for efficiency and accuracy in research.
Key Features
- High-definition imaging system
- User-defined parameters for cell size, brightness, and roundness
- 15s bright field mode and 3s fast counting mode
- Built-in dilution calculator
- Stores up to 1,000 historical counts
Specifications
- Amplification Factor: 2.5, 5 mega-pixel
- Focus Method: Manual & Autofocusing (less than 3s)
- Counting Area: 2.15 mm x 1.62 mm
- Fluorescence Applications: PI, DAPI, AO/GFP
- Cell Type: Cell lines, stem cells, primary cells
- Cell Size Range: 4-60 µm (Optimal: 7-60 µm)
- Cell Counting Time: Less than 20s
- Languages: Chinese and English
Weight
Imperial: 8.4 Pounds
Metric: 3.81 Kilograms
Shipping Dimensions
Imperial: 9.6 lb x 12.0 lb x 8.4 lb
Metric: 24.38 cm x 30.48 cm x 21.34 cm
Harmonized Code
9027.50.10
Harmonized Code Details
9027.50.10 - Instruments and apparatus for physical or chemical analysis. Chosen due to its functionality in laboratory scientific research, involving cell analysis and counting.
Comments 0
There are currently no public comments.